Kuros Biosciences AG
SIX:KURN
Kuros Biosciences AG
SIX:KURN
Price:
7.19 CHF
0.56%
Market Closed
Updated:
May 13, 2024
Kuros Biosciences AG
Cash from Investing Activities
|
Kuros Biosciences AG
Cash from Investing Activities Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
-CHf326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
-$3.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash from Investing Activities
CHf65.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
-CHf1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kuros Biosciences AG's Cash from Investing Activities?
Cash from Investing Activities
-326k
CHF
-326k
CHF
Based on the financial report for Dec 31, 2023, Kuros Biosciences AG's Cash from Investing Activities amounts to -326k CHF.
What is Kuros Biosciences AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
13%
13%
Over the last year, the Cash from Investing Activities growth was 19%. The average annual Cash from Investing Activities growth rates for Kuros Biosciences AG have been -14% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
